Morgan Lewis-Guided Biotech Firm Scores $101.5M From IPO
Venture capital-backed Replimune Group Inc., represented by Morgan Lewis & Bockius LLP, on Friday picked up $101.5 million from its initial public offering as the cancer-focused biotechnology firm finished above its...To view the full article, register now.
Already a subscriber? Click here to view full article